American International Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

American International Group’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,400	Closed	-$24	–	3323
2021 Q1	$24	Buy	7,400 +19	+0.3%	+$78	﹤0.01%	3108
2020 Q4	$30	Sell	7,381 -357	-5%	-$2.06K	﹤0.01%	3049
2020 Q3	$42K	Buy	7,738 +430	+6%	+$2.48K	﹤0.01%	2937
2020 Q2	$49K	Buy	7,308 +2,094	+40%	+$10.2K	﹤0.01%	2889
2020 Q1	$17K	Buy	5,214 +268	+5%	+$1.43K	﹤0.01%	2953
2019 Q4	$35K	Sell	4,946 -98	-2%	-$523	﹤0.01%	2954
2019 Q3	$19K	Sell	5,044 -36	-0.7%	-$122	﹤0.01%	3031
2019 Q2	$19K	Sell	5,080 -1,139	-18%	-$3.79K	﹤0.01%	3059
2019 Q1	$22K	Sell	6,219 -201	-3%	-$1.48K	﹤0.01%	2991
2018 Q4	$50K	Buy	+6,420	New	+$51.4K	﹤0.01%	2889

Other funds holding RVLP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American International Group's RVLP Position: Q2 2021 in Review

American International Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 7,400 shares — an estimated $24 sold.

American International Group first reported a position in RVLP in Q4 2018 and held it in 10 quarters. The position peaked at $50K in Q4 2018. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

American International Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
American International Group sold 7,400 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $24.
American International Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 10 quarters.
American International Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $50K in Q4 2018.
46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.